Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD).
Tilloy V, Díaz-González D, Laplace L, Bisserier E, Chou S, Rawlinson WD, Boivin G, Baldanti F, Lazzarotto T, Andrei G, Hirsch HH, Marcos MÁ, Michel D, Hantz S, Alain S. Tilloy V, et al. Among authors: rawlinson wd. Antiviral Res. 2024 Nov;231:106016. doi: 10.1016/j.antiviral.2024.106016. Epub 2024 Sep 28. Antiviral Res. 2024. PMID: 39349222
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach.
Li V, McKay FC, Tscharke DC, Smith C, Khanna R, Lechner-Scott J, Rawlinson WD, Lloyd AR, Taylor BV, Morahan JM, Steinman L, Giovannoni G, Bar-Or A, Levy M, Drosu N, Potter A, Caswell N, Smith L, Brady EC, Frost B, Hodgkinson S, Hardy TA, Broadley SA; Australian Anti-EBV Drugs for MS Working Group. Li V, et al. Among authors: rawlinson wd. CNS Drugs. 2025 Jan 10. doi: 10.1007/s40263-024-01153-5. Online ahead of print. CNS Drugs. 2025. PMID: 39792343
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies.
Mazigi O, Langley DB, Henry JY, Burnett DL, Sobti M, Walker GJ, Rouet R, Balachandran H, Lenthall H, Jackson J, Ubiparipovic S, Schofield P, Brown SHJ, Schulz SR, Hoffmann M, Pöhlmann S, Post J, Martinello M, Ahlenstiel G, Kelleher A, Rawlinson WD, Turville SG, Bull RA, Stewart AG, Jäck HM, Goodnow CC, Christ D. Mazigi O, et al. Among authors: rawlinson wd. Proc Natl Acad Sci U S A. 2025 Jan 7;122(1):e2417544121. doi: 10.1073/pnas.2417544121. Epub 2025 Jan 2. Proc Natl Acad Sci U S A. 2025. PMID: 39746041 Free article.
Emerging concepts of CMV in transplantation.
Westall GP, Gottlieb D, Hughes P, Marinelli T, Rawlinson WD, Ritchie D, Sasadeusz J, Yong MK. Westall GP, et al. Among authors: rawlinson wd. Intern Med J. 2024 Dec 2. doi: 10.1111/imj.16587. Online ahead of print. Intern Med J. 2024. PMID: 39620697 Review.
Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic.
Akerman A, Fichter C, Milogiannakis V, Esneau C, Silva MR, Ison T, Lopez JA, Naing Z, Caguicla J, Amatayakul-Chantler S, Roth N, Manni S, Hauser T, Barnes T, Boss T, Condylios A, Yeang M, Sato K, Bartlett NN, Darley D, Matthews G, Stark DJ, Promsri S, Rawlinson WD, Murrell B, Kelleher AD, Dwyer D, Sintchenko V, Kok J, Ellis S, Marris K, Knight E, Hoad VC, Irving DO, Gosbell I, Brilot F, Wood J, Aggarwal A, Turville SG. Akerman A, et al. Among authors: rawlinson wd. EBioMedicine. 2024 Dec;110:105415. doi: 10.1016/j.ebiom.2024.105415. Epub 2024 Nov 15. EBioMedicine. 2024. PMID: 39549677 Free PMC article.
313 results